[144] CoreWeave, Inc. SEC Filing

Rhea-AI Filing Summary

CoreWeave, Inc. (CRWV) filed a Form 144 notifying a proposed sale of 21,531 shares of common stock through Morgan Stanley Smith Barney LLC with an aggregate market value of $2,000,014.59. The filing lists approximately 370,470,348 shares outstanding and an approximate sale date of 08/20/2025 on NASDAQ. The shares were acquired as Founders Shares from the issuer on 12/27/2023, with payment recorded on that same date. The filer reports no securities sold in the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information.

Positive

• Brokered sale through a major firm (Morgan Stanley Smith Barney LLC) indicating formal execution and clearance.
• No sales in the prior three months reported, suggesting this is an isolated planned transaction by the filer.

Negative

• None.

Insights

Securities Analyst

TL;DR: Insider plans to sell a small block of founder shares valued at about $2.0M, representing a minor fraction of outstanding stock.

The notice documents an intended sale of 21,531 founder-issued common shares via Morgan Stanley Smith Barney LLC at an aggregate market value of $2,000,014.59, with an approximate trade date of 08/20/2025. Relative to the reported 370,470,348 shares outstanding, this block is immaterial in size. The filing confirms acquisition date of 12/27/2023 and that no other sales occurred in the prior three months. The form includes the standard attestation regarding undisclosed material information and references Rule 144 procedures for restricted/controlled shares.

Corporate Governance Expert

TL;DR: The Form 144 is routine disclosure of an insider sale; no governance red flags are evident from the content provided.

The document shows the sale involves founder shares obtained from the issuer and lists the brokerage firm handling the transaction. There are no disclosures here of accelerated sales, clustering of trades, or prior recent sales by the same person. The required statement that the seller is unaware of undisclosed material adverse information is included. Based solely on this filing, the transaction appears to follow standard regulatory notice requirements.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	21531	2000014.59	370470348	08/20/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/27/2023	Founders Shares	Issuer			21531	12/27/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What securities did CoreWeave (CRWV) report for sale on Form 144?

The filer reported 21,531 common shares of CoreWeave for sale.

What is the aggregate market value of the shares listed on the Form 144 for CRWV?

The aggregate market value is reported as $2,000,014.59.

When were the shares to be sold and on which exchange for CRWV?

The approximate sale date is 08/20/2025 and the sale is listed on NASDAQ.

How and when were the reported shares of CRWV acquired?

The shares were acquired as Founders Shares from the issuer on 12/27/2023.

Did the filer report any securities sold during the past three months for CRWV?

The filing states "Nothing to Report" for securities sold in the past three months.